0001232524-17-000059.txt : 20170306
0001232524-17-000059.hdr.sgml : 20170306
20170306185113
ACCESSION NUMBER: 0001232524-17-000059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170302
FILED AS OF DATE: 20170306
DATE AS OF CHANGE: 20170306
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jazz Pharmaceuticals plc
CENTRAL INDEX KEY: 0001232524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981032470
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4TH FLOOR, CONNAUGHT HOUSE
STREET 2: ONE BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 353-1-634-7800
MAIL ADDRESS:
STREET 1: 4TH FLOOR, CONNAUGHT HOUSE
STREET 2: ONE BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: JAZZ PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McGill Iain
CENTRAL INDEX KEY: 0001615764
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33500
FILM NUMBER: 17669224
MAIL ADDRESS:
STREET 1: C/O JAZZ PHARMACEUTICALS PLC
STREET 2: 4TH FL, CONNAUGHT HOUSE, 1 BURLINGTON RD
CITY: DUBLIN
STATE: L2
ZIP: 4
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2017-03-02
0
0001232524
Jazz Pharmaceuticals plc
JAZZ
0001615764
McGill Iain
CONNAUGHT HOUSE, 1 BURLINGTON RD, FL. 4
DUBLIN 4
L2
IRELAND
0
1
0
0
SVP, Europe & Rest of World
Ordinary Shares
2017-03-02
4
A
0
4500
0.0
A
21201
D
Non-Qualified Stock Option (right to buy)
136.18
2017-03-02
4
A
0
11250
0.0
A
2027-03-01
Ordinary Shares
11250
11250
D
These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2017, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.
By: /s/Peter A Christou, as attorney in fact For: Iain McGill
2017-03-06